Skip to content
knowrare
HealthSignal
Your condition community

Living with Transitional cell carcinoma

A cancer that starts in the lining of the urinary tract, most often in the bladder, ureter, or kidney's collecting area.

Understanding Transitional cell carcinoma

Transitional cell carcinoma is a cancer that starts in the transitional cells that line the urinary tract, usually the bladder, ureter, or renal pelvis.

It may or may not have a finger-like (papillary) shape. Doctors grade it from 1 to 3 or 4 by how different the cells look from normal ones. Grade 1 looks benign under a microscope but may come back. It can also affect the upper airway and the ovaries.

Signs & symptoms

GARD doesn't list specific symptoms for this condition yet.

Not everyone has every symptom. GARD's list comes from the Human Phenotype Ontology.

Diagnosis

  1. Talk with your doctor

    Share the symptoms you've noticed, when they started and your family health history. Notes and photos can help.

  2. See a specialist

    Your doctor may refer you to a specialist who knows rare conditions.

  3. Ask which tests can help

    Your care team will decide which exams and tests can confirm the diagnosis.

Care & treatment

Care team
A doctor familiar with rare conditions, plus specialists as needed
Expert care
Ask about multidisciplinary care centers for rare conditions
Treatment
GARD doesn't list specific treatments for this condition. Your care team will tailor care to your symptoms.
Research
Clinical trials and observational studies may be options. See the research section below.

General information, not medical advice. Your care team makes the decisions.

Everyday life

Living with a rare condition is easier with support.

  • Connect with American Cancer Society
  • Keep notes on symptoms, changes and questions for appointments
  • Ask about patient registries that help research
  • Look into financial aid and travel resources for care visits
Bring these questions to your next doctor visit
What grade and stage is my cancer?
What are my treatment options?
How often will I need follow-up checks, since it may recur?

Quick facts

GARD doesn't describe a cause for this condition yet.

Also known as: carcinoma of transitional epithelial cell; carcinoma of urothelial cell; carcinoma, urothelial, malignant; tcc - transitional cell carcinoma; transitional carcinoma; transitional epithelial cell carcinoma

Patient organizations

Source: NIH GARD · Transitional cell carcinomaGARD ID 7794 · GARD page updated September 2026 · Plain-language summary by Know Rare; editorial review pending. General information, not medical advice.

You are more than your diagnosis

Perspectives from people navigating life with Transitional cell carcinoma.

Explore the Transitional cell carcinoma blog

Explore research for Transitional cell carcinoma

Explore actively recruiting Transitional cell carcinoma studies with HealthSpark.

HealthSpark

Find actively recruiting studies for Transitional cell carcinoma with HealthSpark. Share your city to explore research near you.

  • Recruiting studies from ClinicalTrials.gov
  • Share your city to look for research near you
  • Eligibility is confirmed by the study team

Powered by HealthSpark, our AI chat helper

I can help you find recruiting Transitional cell carcinoma studies. Enter a ZIP code, address or city below and I'll look within 50 miles.

Powered by HealthSpark, our AI chat helper · Study information from ClinicalTrials.gov · Eligibility is confirmed by the study team.

Get Signals for Transitional cell carcinoma

Stay in the loop with community stories and updates from medical researchers.

HealthStoryfor Transitional cell carcinoma

Create a living journal that talks back

HealthStory evolves private journaling with a living AI journal that talks back and asks thoughtful questions, helping you capture your Transitional cell carcinoma experiences more deeply and prepare for better conversations with your doctors and care team.

Start your journal

Your journal is private. Sharing your story publicly is a separate choice, made with Share your story above.